Virtual Reality Headsets to Ease Pain in Children With Cancer
Tests virtual reality headsets to reduce pain during procedures in children with cancer.
Plain-language title generated from the registry record
Registry title: Use of Virtual Reality in Pain Management in Pediatric Oncology
Key facts
- Where
- Saint-Denis, RéunionSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers in pediatric oncology who need painful procedures. It tests a virtual reality headset for pain during these procedures.
- Age
- 6 to 18 years
- Sex
- Boys and girls
- Disease stage
- Benign tumor or cancer, followed in pediatric oncology.
Main reasons for not taking part
- Visual or hearing impairment
- Epilepsy or other neurological disease
- Psychiatric disease
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 18 years old?
Source: NCT05592132, who can take part
Where in Réunion
- CHU de La RéunionSaint-Denis, RéunionContact: Yves REGUERRE, MDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Centre Hospitalier Universitaire de la Réunion
- Trial code
- NCT05592132
- Record updated
- 11 September 2026
- Original description
DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.Read full original descriptionShow less
Use of Virtual Reality in Pain Management During Invasive Gestures in Pediatric Oncology: Randomized Controlled Trial
DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.
Inclusion: patient who tolerates the virtual reality headset; patient followed in pediatric oncology; patient with a diagnosis of benign tumor or cancer; patient who needs to have painful medical procedure during their treatment; patient whose parents have signed the informed consent; patient affiliated with social security or equivalent.
Exclusion: patient with epilepsy or other neurological disease; patient with psychiatric disease; patient with visual or hearing impairement.